12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2